Objectives: Evaluation of sleep quality in COPD and relationship of PSQI (Pittsburgh Sleep Quality Index) score with health related quality of life, depression, anxiety and severity of airflow obstruction.
Introduction
COPD patients are often associated with many extra pulmonary comorbidities and these comor-Correspondence to: Dr. Mohammad T. Abd El-Fattah, The Department of Chest Diseases, Faculty of Medicine, Minia University, Egypt bidities contribute to the severity of the disease in selected patients [1] . Poor quality of sleep pattern together with other disturbances in sleep is common in patients with COPD [2] [3] [4] . There are significant differences between the sleep disorders in general population and disorders found in COPD patients [5] .
In patients with stable COPD sleep quality is one of important indicators of quality of life [2, 3] . The mechanisms responsible for poor sleep quality in COPD are currently not well known. Many mechanisms may be included as; cough or dyspnea [6] , nocturnal oxygen desaturation [7] , hypercapnia [8] or daytime hypoxemia. A recent study showed that; Melatonin might have a positive effect on sleep quality in patients with COPD [2] . Anxiety and depression have been associated with poor sleep quality [9] . Health Related Quality of Life (HrQOL) in COPD has been influenced by poor sleep quality [10] . This study was performed to evaluate subjective assessment of sleep quality in clinically stable COPD patients using Pittsburg questionnaire and to assess the relationship of PSQI score with health related quality of life using SGRQ, depression using Beck score, anxiety using Hamilton score and severity of airflow obstruction.
Patients and Methods
The present study was a prospective case control study that was conducted in the Chest Department, COPD and its severity were defined according to GOLD guideline. COPD was diagnosed by the presence of chronic symptoms (chronic productive cough and dyspnea) and post-bronchodilator FEV 1 / FVC <70. COPD severity was defined as mild when post-bronchodilator FEV 1 from 50-79, mild when post-bronchodilator FEV 1 ≥ 80% predicted, moderate when post-bronchodilator FEV 1 from 50-79% predicted, severe when post-bronchodilator FEV 1 from 30-49% predicted, very severe when post-bronchodilator FEV 1 <30% predicted [1] . Spirometry was performed by using spirometer (Lab Digital Spirometer 762600, Sensor medics). Grading of dyspnea was based on modified Medical Research Council (mMRC) dyspnea scale [11] . Exercise performance was assessed using the Six Minute Walk Test [12] . The primary outcome was distance walked in 6 minutes.
Pittsburgh Sleep Quality Index (PSQI) is a 19item self-rating scale designed to measure the quality of sleep during the previous month using seven components of sleep i.e., sleep quality, sleep latency, sleep duration, sleep efficiency and sleep disturbance, use of sleep medications and daytime dysfunction [13] . The scale yields a total score that ranges from 0 to 21, with higher scores indicating more difficulties with sleep. A global score greater than 5 indicates a poor sleeper.
Berlin questionnaire was utilized for evaluation of sleep apnea. It contains 10 questions about risk factors of sleep apnea such as snoring, daytime sleepiness and fatigue, obesity, and hypertension. If the individual scores positive in at least two of the three categories, he/she are at high risk of sleep apnea [14] .
Epworth Sleepiness Scale (ESS) questionnaire was employed for analysis of daytime sleepiness. It comprises 8 questions that depict situations in which the individual may become sleepy reluctantly. Each question takes 0 to 3 scores. If the patient's score is higher than 10, he/she have more than usual daytime sleepiness [15] . Saint George respiratory questionnaire was used for assessment of quality of life of the patients. It contains 76 items about symptoms, impact, and activity of the disease, which provide total score according to index of effect of any subscore, from 0 to 100 for individual subscores and totally. Component scores measuring symptoms (Symptoms), impacts on daily life (Impacts), disturbance to daily activities (Activity), and an overall (Total) score are normally calculated. Higher score means lower quality of life in those subscores. It has been used in many diseases included lung disease such as asthma and COPD. Content of its questions is simple and easily understood by patients [16] .
Anxiety was assessed by Hamilton Anxiety (HAM-A) :
It is a 14-items anxiety self-test, which gives a score on an anxiety scale [17] . Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score ranges from 0-56. A total score of 18 or more means anxiety, 18-24: Mild anxiety, 25-29: Moderate anxiety, 30 and above: Severe anxiety.
Depression was assessed by Beck's Depression Inventory (BDI):
The Beck Depression Inventory, 2nd edition (BDI; Beck, Steer et al., 1996), a 21item self-report measure of depression, was used to assess severity of depression. The BDI possesses strong internal consistency, factorial and convergent validity, and test-retest stability [18] , and it has been validated for use with medical patients [19] . Total scores ranging from 0 to 13 are indicative of minimal depression, 14-19 of mild depression, 20-28 of moderate depression, and 29-63 of severe depression.
Statistical analysis:
Statistical analysis was performed using SPSS software Version (12.0; SPSS Inc., Chicago). Results are expressed as the mean and Standard Deviation (SD) for continuous variables and as percentages for categorical variables. Differences in continuous variables were assessed by student's t-test and ANOVA. Chi-square test was used to determine the association between categorical variables. Correlation between PSQI scores and other variables were assessed by the Spearman rank correlation coefficient ( r). A p-value of less than 0.05 was considered as statistically significant.
Results
Table (1) demonstrates the demographic and characteristic data in COPD patients and control healthy subjects. The mean age of the whole subjects included in the study was ranged from 44 to 83 years with a mean of 61.2 ± 8.1 years. Males represented 75% of patients in COPD patients and 64.3% of control subjects. Both groups are matched as regard age, sex, BMI and education state. 53.2% of the 124 COPD patients had poor sleep quality (indicated by high PSQI >5) and 50% of them had high risk of OSA (indicated by Berlin questionnaire positive in at least 2 of the 3 categories). There was statistically significant difference between both groups regarding smoking index, spirometric parameters, 6-min walk test, Berlin questionnaire, PSQT, ESS, BDI and HAM-A. Table ( 2) demonstrates other characteristics of COPD patients. The most frequent comorbid disorder associated with COPD was cardiac diseases followed by hypertension and then diabetes mellitus. Table ( 3) demonstrates comparison between COPD patients with poor sleep quality and those with good sleep quality. COPD patients with poor sleep quality (indicated by high PSQI >5) had statistically significant higher number of exacerbations, COPD duration, cough symptomatology and use of LAMA. In COPD patients with poor sleep quality FEV 1 , FVC% and PEF25-57% and pH were significantly lower and PCO 2 was significantly higher. As regard spirometric parameters, there was statistically significant difference between both groups as regard FEV 1 , FVC% and PEF25-57%, that was significantly lower in COPD patients with poor sleep quality. COPD patients with poor sleep quality had statistically significant lower pH and higher PaCO 2 . COPD patients with poor sleep quality had statistically significant higher total The proportions of patients with poor sleep quality that reported high risk of OSA (74.1%) was significantly higher than patients with low risk of OSA (28.8%). Also, the proportion of patients with poor sleep quality that had low ESS (47%) was significantly higher than patients with high ESS (0%) Table (4). (5) demonstrates comparison between COPD patients with high risk of OSA and those with low risk of OSA. COPD patients with high risk of OSA (indicated by Berlin questionnaire positive in at least 2 of the 3 categories) had statistically significant higher number of exacerbations and lower FEV 1 %, PEF25-57% than those with good sleep quality. COPD patients with poor sleep quality had statistically significant shorter 6-min walk distance and higher total SGRQ, ESS, PSQI, BDI and HAM-A. The proportion of patients with high risk of OSA that reported poor quality of sleep was significantly higher than patients with low risk of OSA Table (6) . Table (7) demonstrates correlation between PSQI and other patient's characteristics. PSQI correlated positively with COPD duration, number of exacerbation, PCO 2, HAM-A, BDI and SGRQ. PSQI correlated negatively with FEV 1 %, FVC%, FEF25-75%, use of LAMA and 6-min walk distance. 
Discussion
Sleep disturbance in COPD patients are frequent and it leads to nonspecific daytime chronic fatigue, lethargy and overall impairment in quality of life. Thus, overall sense of well-being can be improved by accurate diagnosis and management of sleep disorders in COPD patients [2] .
The present study found that 53.2% of COPD patients had poor sleep quality (indicated by PSQI >5) that was significantly higher than those in control group without COPD. This is consistent with previous studies [2, 3] . Chang et al., [20] reported similar results. In a study of 59 patients with moderate to severe COPD, Lewis et al., [21] showed that Poor Sleep Quality (PSQI >5) in 61% of COPD patients regardless of their advanced age. Other two studies showed higher values (78% and 78.1%) [22, 23] . However, the patients numbers in those studies was small (28 and 64 patients respectively).
Sleep disorders in COPD patients appear to have multifactorial and complex mechanisms.
Many factors appear to be involved including; physiological changes associated with sleep, hypoxemia, hypercapnia. In addition, inflammation, medications used for COPD treatment, and/or nicotine use can be included. Other associated comorbidities and primary sleep disorders are included in the mechanism of sleep disorders in COPD patients; [24] .
Negative correlation was found between PSQI value and FEV 1 , FVC and FEF25-75%. In consist-. ent to our results, In et al., [25] found negative correlation between PSQI and FEV 1 % and FVC%. Also Sajal et al., [26] reported that FVC, and FEV 1 were considered as independent variables to predict global PSQI scores. As regard relationship, either between the degree of airflow obstruction (FEV 1 %) and sleep quality (PSQI) or between GOLD class and sleep quality Scharf et al., found statistically insignificant difference [3] . In contrast to the previous results PaCO 2 was a significantly higher in patients with poor sleep quality ( p=0.009). These results in agreement with a previous study [27] . Hypercarpia has been shown to increase sympathetic activity in some studies [28, 29] . 87.9% of patients with poor sleep quality have cough which is significantly higher than in patients with good sleep quality (p=0.04). Other studies results come in agreement with our study, which showed that associated cough and sputum production appear to be important predictors of sleep disturbances [6, 30] . The present study showed no association between sleep quality with age that is consistent with previous studies [3, 6] . There was also no association between sleep qualities with smoking. This is in agreement with a previous study [31] . However, a recent study found that smoking was associated with sleep initiation and sleep fragmentation [32] . Medications used for treatment of COPD e.g., salbutamol, theophylline, steroid can affect the sleep quality. However, previous studies did not demonstrate any correlation between sleep quality and the use of such treatments in COPD [33, 34] . In our study, the use of inhaled long acting muscarinic antagonists was associated with good sleep quality in the COPD patients. This is consistent with two previous studies [4, 34] . This could be due to the better control of symptoms with the addition of inhaled LAMA to the usual treatment of COPD patients.
In the present study poor sleep quality was significantly associated with increased number of acute exacerbation ( p=0.02). This comes in agreement with other studies [6, 35, 36] . Whether poor sleep quality precipitate AECOPD or AECOPD be a contributing factor to poor sleep quality in COPD is difficult to determine from our results. Sleep disorders is a documented risk factor for some comorbidities such as; glucose intolerance, hypertension, cardiovascular disease, and can increase airflow obstruction in COPD and hence precipitating exacerbations [25] . On the other hand, AECOPD could worsen sleep quality through increased symptomatology, aggravating hypoxemia and hypercarpia, increased level of systemic inflammation, and increased medication used. Poor sleep quality and AECOP are considered common pathophysiological mechanisms including; higher levels of proinflammatory cytokines, high burden of airway pathogens, and undiagnosed sleep disordered breathing [25] .
The present study found that 50% of COPD patients had increased risk of OSA (indicated by categories 2 or 3 Berlin questionnaire), compared to 21.4% in normal subjects without COPD. In consistent with our study, Zohal et al., [35] reported that about half of 139 COPD patients had increased risk of OSA. Bellia et al., [37] reported one or more sleep disturbances were reported by 60.6% (445 out of 734 patients with chronic airway diseases) vs. 56.4% (697 out of 1237 controls normal subjects). Another study found a prevalence of OSA in moderate-to-severe COPD patients of 66% [38] . The higher concurrence rate of OSA and COPD can be attributed to several factors other than only chance. The chronic oral steroids used by some patients with severe COPD may cause central obesity and deposition of fat in the neck, which in turn increase the risk of OSA. Right ventricular dysfunction and right heart failure that can occur as a complication of COPD may cause edema in the pharyngeal soft tissues, which can predispose to OSA. COPD is a cause of limited exercise capacity and hence contribute to obesity, which is a risk factor for OSA. The generalized muscle weakness associated with COPD could promote also upper airway collapsibility [25] . In contrast to our study, some studies reported no increase in the prevalence of OSA among COPD patients comparing to the general population [39, 40] . The controversy regarding whether sleep apnea prevalence is higher in COPD as compared to matched individuals without COPD could be attributed to the heterogeneity of the studied patients in different studies, the different diagnostic techniques used, and to the different associated risk factors in the cohort being studied.
In the present study, only 25% of COPD patients had excessive sleepiness as assessed by the ESS score. Although higher percentage (53.2%) had poor sleep quality as assessed by the PSQI. This is consistent with Scharf et al., study [3] . Insomnia without excessive sleepiness was an important sleep complaint reported by our patients. The causes for the discrepancy between the high prevalence of poor sleep quality and the lack of excessive sleepiness are not obvious. Medication use, sympathetic hyperstimulation, or anxiety all can cause a hyper alert state, which in turn decreasing the extent of excessive sleepiness [3] . Other possible causes might include cultural background of some patients and some patients do not like to admit that; they are sleepy.
We reported a mean SGRQ score of 68.2. Scharf et al., [3] reported a mean SGRQ score of 57.0. While, other studies have reported lower mean SGRQ scores [2, 4] . In our study, mean SGRQ score (total, symptom, impact, activity and impact) are significantly higher in COPD patients with poor sleep quality. In consistent to our results, PSQI Index was found to be an independent predictor of quality of life in COPD patients in Scharf et al., study [3] . In our study, PSQI was found to be correlated with SGRQ (total, symptoms, activity and impact). This means that sleep quality predicts overall and disease-specific health related quality of life. These results are in agreement with previous results [2] [3] [4] .
In the present study, we found strong correlation between depression and anxiety scores and sleep indices (PSQI, ESS). This finding confirms the established relationship between sleep disturbances in depression and anxiety [6, 41, 42] . Depressive symptoms were found to have strong association with subjective sleep quality and moderately associated with objective sleep quality [43] . Tsuno et al., [44] reported that 90% of patients with depression are troubled with poor sleep quality. They also found that in 40% of cases sleep complaints occurs before an episode of depression. Suh et al., [45] found that COPD patients with anxiety have significantly higher PSQI than patients without anxiety (12.0 versus 6.9 respectively).
Conclusion:
Our study concluded that COPD patients have poor sleep quality and high risk of OSA. There is strong association between poor sleep quality and physical limitation, COPD exacerbation, anxiety, depression and poor health related quality of life. The main limitations of this study are the lack of objective data as those obtained from polysomnography.
